| Literature DB >> 35909977 |
Manjari Shukla1, Vineeta Singh1, Hamza Habeeballah2, Mustfa F Alkhanani3, Manjul Lata4,5, Yusuf Hussain5,6, Madhuparna Mukherjee7, Mukesh Pasupuleti4,5, Abha Meena5,6, Bhartendu Nath Mishra1, Shafiul Haque8.
Abstract
The inhibition/degradation potential of Carissa carandas proteinaceous leaf extract against mixed bacterial biofilm of Staphylococcus aureus MTCC 96, Escherichia coli MTCC 1304, Pseudomonas aeruginosa MTCC 741, and Klebsiella pneumoniae MTCC 109, responsible for nosocomial infections, was evaluated. Distinct inhibition/degradation of mixed bacterial biofilm by the proteinaceous leaf extract of C. carandas was observed under a microscope, and it was found to be 80%. For mono-species biofilm, the maximum degradation of 70% was observed against S. aureus biofilm. The efficiency of aqueous plant extracts to inhibit the mono-species biofilm was observed in terms of minimum inhibitory concentration (MIC), and the best was found against P. aeruginosa (12.5 μg/ml). The presence of flavonoids, phenols, and tannins in the phytochemical analysis of the plant extract suggests the main reason for the antibiofilm property of C. carandas. From the aqueous extract, protein fraction was precipitated using 70% ammonium sulfate and dialyzed. This fraction was purified by ion-exchange chromatography and found to be stable and active at 10°C (pH 7). The purified fraction showed less than 40% cytotoxicity, which suggests that it can be explored for therapeutic purposes after in-depth testing. In order to investigate the mechanistic action of the biofilm inhibition, the plant protein was tested against Chromobacterium violaceum CV026, and its inhibitory effect confirmed its quorum quenching nature. Based on these experimental analyses, it can be speculated that the isolated plant protein might influence the signaling molecule that leads to the inhibition effect of the mixed bacterial biofilm. Further experimental studies are warranted to validate our current findings.Entities:
Keywords: biofilm; nosocomial infection; quorum quenching; quorum sensing; virulence
Mesh:
Substances:
Year: 2022 PMID: 35909977 PMCID: PMC9329584 DOI: 10.3389/fcimb.2022.836819
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Phytochemical testing of different extracts of plant Carissa carandas.
| Phytochemical Extract | Car | Flv | Gly | Phe | Cou | Tan | Ter | Qui | Prt | Ps | Sap | RS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Filtrate | + | + | + | + | − | − | + | − | + | − | + | + |
| Precipitate | − | − | + | + | − | − | + | − | + | − | + | + |
| Dialyzed sample | − | − | − | + | − | − | + | − | + | − | + | + |
| Column Fractions | − | − | − | + | − | − | − | − | + | − | − | + |
Car, carbohydrate; Flv, flavonoid; Gly, glycoside; Phe, phenol; Cou, coumarin; Tan, tannin; Ter, terpenoid; Qui, quinone; Prt, protein; Ps, phytosterol; Sap, saponin; RS, reducing sugar.
Figure 1Liquid chromatography–tandem mass spectrometry (LC-MS) analysis of active column passed fractions collected at retention times of 19.88 (A) and 20.96 (B).
Figure 2Effect of various factors (temperature, pH, solvents, and metal ions) on plant protein activity.
Minimum inhibitory concentration of the selected plant protein (in μg/ml).
| Microorganism | Chloramphenicol (D1) | Ampicillin (D2) | Cefotaxime (D3) |
|
|
| 25 | 100 | 12.5 | 100 |
|
| 12.5 | 25 | 12.5 | 100 |
|
| 6.25 | 6.25 | 100 | 50 |
|
| 6.25 | 6.25 | 50 | 12.5 |
|
| 6.25 | 6.25 | 25 | 100 |
| Mixed biofilm | 12.5 | 12.5 | 100 | 50 |
Figure 3Percentage cytotoxicity vs. concentration of extract. NS = Non significant; * = Significant.
Percentage inhibition (I) and degradation (D) observed by the plant extract of Carissa carandas.
| Microorganism |
|
|
|
|
| Mixed | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | D | I | D | I | D | I | D | I | D | I | D | |
| Ampicillin (D2) (100 μl) | 94 | 44 | 90 | 34 | 88 | 64 | 90 | 36 | 95 | 78 | 90 | 67 |
| Ampicillin (D2) (50 μl) | 80 | 22 | 80 | 22 | 65 | 76 | 77 | 78 | 90 | 65 | 82 | 40 |
| Cefotaxime (D3) (100 μl) | 96 | 43 | 92 | 48 | 90 | 57 | 90 | 72 | 92 | 73 | 92 | 82 |
| Cefotaxime (D3) (50 μl) | 80 | 33 | 80 | 48 | 77 | 40 | 85 | 69 | 87 | 65 | 78 | 60 |
| Compound (100 μl) | 50 | 40 | 63 | 28 | 80 | 70 | 78 | 66 | 90 | 60 | 80 | 60 |
| Compound (50 μl) | 42 | 32 | 50 | 10 | 70 | 60 | 66 | 50 | 80 | 48 | 72 | 50 |
Figure 4Fluorescence microscopic image showing degradation of biofilm when treated with the protein extract of Carissa carandas leaves. (A) Control (non-treated). (B) After 24-h treatment.
Figure 5Microscopic analysis of the effect of compounds on mixed biofilm. (A) Biofilm formed by mixed microbes (S.a, K.p, E.c, P.a, and C.v). (B) Biofilm formation inhibition by selected compound extracellular polymeric substances (EPS) extraction and analysis. (C) Carbohydrate. (D) Protein. (E) Lipid content of the biofilm EPS. S.a, Staphylococcus aureus; K.p, Klebsiella pneumoniae; E.c, Escherichia coli; P.a, Pseudomonas aeruginosa; C.v, Chromobacterium violaceum.
Effect of selected plant extract on the EPS inhibition and analysis of its content.
| Microorganisms | Without treatment | With treatment | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| Mixed |
|
|
|
| Mixed | ||
| Biomass (g) | 12.38 | 12.80 | 14.00 | 14.38 | 12.978 | 11.28 | 11.71 | 12.74 | 8.688 | 10.048 | |
| EPS (mg) | 60 | 148 | 310 | 200 | 410 | 40 | 100 | 200 | 150 | 300 | |
| Total carbohydrate (mg/ml) | 0.142 | 0.222 | 0.217 | 0.227 | 0.223 | 0.097 | 0.168 | 0.170 | 0.187 | 0.180 | |
| Total reducing sugar (mg/ml) | 0.030 | 0.019 | 0.014 | 0.090 | 0.081 | 0.020 | 0.010 | 0.018 | 0.040 | 0.015 | |
| Total protein (mg/ml) | 0.373 | 0.40 | 0.220 | 0.19 | 0.304 | 0.23 | 0.35 | 0.20 | 0.10 | 0.23 | |
K.p, Klebsiella pneumoniae; P.a, Pseudomonas aeruginosa; E.c, Escherichia coli; S.a, Staphylococcus aureus; C.v, Chromobacterium violaceum; EPS, extracellular polymeric substances.